1. Home
  2. CNTX vs PNBK Comparison

CNTX vs PNBK Comparison

Compare CNTX & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • PNBK
  • Stock Information
  • Founded
  • CNTX 2015
  • PNBK 1999
  • Country
  • CNTX United States
  • PNBK United States
  • Employees
  • CNTX N/A
  • PNBK N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • PNBK Major Banks
  • Sector
  • CNTX Health Care
  • PNBK Finance
  • Exchange
  • CNTX Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • CNTX 78.0M
  • PNBK 84.4M
  • IPO Year
  • CNTX 2021
  • PNBK N/A
  • Fundamental
  • Price
  • CNTX $0.79
  • PNBK $1.58
  • Analyst Decision
  • CNTX Strong Buy
  • PNBK
  • Analyst Count
  • CNTX 5
  • PNBK 0
  • Target Price
  • CNTX $5.25
  • PNBK N/A
  • AVG Volume (30 Days)
  • CNTX 145.6K
  • PNBK 361.4K
  • Earning Date
  • CNTX 08-06-2025
  • PNBK 08-26-2025
  • Dividend Yield
  • CNTX N/A
  • PNBK N/A
  • EPS Growth
  • CNTX N/A
  • PNBK N/A
  • EPS
  • CNTX N/A
  • PNBK N/A
  • Revenue
  • CNTX N/A
  • PNBK $15,640,000.00
  • Revenue This Year
  • CNTX N/A
  • PNBK N/A
  • Revenue Next Year
  • CNTX N/A
  • PNBK N/A
  • P/E Ratio
  • CNTX N/A
  • PNBK N/A
  • Revenue Growth
  • CNTX N/A
  • PNBK N/A
  • 52 Week Low
  • CNTX $0.49
  • PNBK $0.90
  • 52 Week High
  • CNTX $2.70
  • PNBK $7.47
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 58.08
  • PNBK 47.54
  • Support Level
  • CNTX $0.68
  • PNBK $1.50
  • Resistance Level
  • CNTX $0.73
  • PNBK $1.85
  • Average True Range (ATR)
  • CNTX 0.05
  • PNBK 0.15
  • MACD
  • CNTX -0.00
  • PNBK -0.00
  • Stochastic Oscillator
  • CNTX 55.65
  • PNBK 19.05

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: